*University of Health Sciences/The Chicago Medical School **Illinois Institute of Technology (312) ABSTRACT INTRODUCTION.

Size: px
Start display at page:

Download "*University of Health Sciences/The Chicago Medical School **Illinois Institute of Technology (312) 578-3213 ABSTRACT INTRODUCTION."

Transcription

1 MAINTAINING A KNOWLEDGE BASE USING THE MEDAS KNOWLEDGE ENGINEERING TOOLS Frank Naeymi-Rad*, Martha Evens**, Timothy Koschmann* Chui-Mei Lee* Rao Y.C Gudipati *, Theresa Kepic*, Eric Rackow*, Max Harry Weil* *University of Health Sciences/The Chicago Medical School **Illinois Institute of Technology (312) ABSTRACT This paper describes the process by which a medical expert creates a new knowledge base for MEDAS, the Medical Emergency Decision Assistance System. It follows the expert physician step by step as a new disorder is entered along with its relevant symptoms. As the expanded knowledge base is tested, inconsistencies are detected, and corrections are made, showing at each step the available tools and giving an example of their use. INTRODUCTION This paper describes a set of Knowledge Engineering Tools developed to make it easy for physicians to add medical expertise to the knowledge base of MEDAS, the Medical Emergency Decision Assistance System. MEDAS is the outgrowth of almost ten years of research on pattern recognition and expert systems carried on originally at the University of Southern California and continued for the last two years at the Chicago Medical School. It differs from most other medical expert systems in applying advanced pattern recognition concepts to the problems of diagnosis. The system currently contains information about eighty-seven lifethreatening diseases that show up most frequently in emergency rooms and critical care facilities. The system provides differential diagnoses based on approximately 780 features (symptoms, physical signs and results of objective [laboratory, imaging] tests). A year ago while expanding MEDAS, the details of which are described below, it became obvious to us that a physician attempting to enter a new disease or a new test was faced with the almost impossible task of tracing through lists of meaningless numbers. What is more, we had no way of detecting inconsistencies and no facilities for making corrections. The MEDAS TOOLBOX was created using Accent-it (Relational Data Base) to provide the expert physician with a comfortable interface for entering information into the system, detecting errors, and correcting them. We show here how a medical expert uses the TOOLBOX to create a new knowledge base. The importance of knowledge engineering tools is stressed by Buchanan and Shortliffe 3. Without tools the expert has to explain his expert knowledge to the knowledge engineer and leave it to that intermediary to encode what he knows. This estranges the expert from the system and diffuses responsibility for validation, moreover it increases the error rate and compromises the reliability of the system. We have tried tools that do for MEDAS some, at least, of what Teiresias 4 does for MYCIN, tools that help the physician transfer knowledge directly to the system without the need of an intermediary, and also tools which help identify inconsistencies and errors. The MEDAS System MEDAS is designed to provide the clinician with assistance in determining diagnosis, ordering tests, and providing treatment. The strategy used in diagnosis is based on a modified version of Bayes' theorem that allows the system to handle patients with more than one disorder. 5 The system develops disorder patterns in terms of collections of features. A feature is any piece of clinical data, age, sex, race, complaints, signs, symptoms, findings from the physical examination, results of tests and diagnostic medical procedures. Computations are based on estimates of the probability that a given symptom will or will not appear in a patient with an identifiable disease or syndrome. Thus the kind of knowledge that the system needs to acquire from the expert is information about disorders, features, and estimated probabilities. To track down errors and inconsistencies in the data base the expert needs information from the system in return about the ways in which features interact and also comparisons between feature patterns for different disorders. The system also needs to acquire treatment protocols from the expert. 6 At the moment these are simply a set of actions to be performed and can be handled with a simple text editor. We plan to increase the sophistication of this part of the system. The addition of a relational data base to MEDAS has made the development of knowledge engineering tools much simpler. 7

2 A year ago the twelve unformatted FORTRAN files used by the then-current version of MEDAS were replaced by a commercial Database Management System on the DEC-20 to make a new system called MEDAS-R. As a result modification of the knowledge base became much easier. In the new system it is also possible to keep track of the source of all information entered into the knowledge base, along with the data and time of the entry. The new system contains two levels, a knowledge maintenance level and a production level. This design makes it possible to certify new disorder patterns before entering them into the production system. Entering a New Disorder Suppose an expert cardiologist wants to enter a disorder, Pulmonary Thromboembolism, into the knowledge base. The physician looks at the TOOLBOX Screen (Fig. 1) and selects the Knowledge Base Entry option. This brings up the Knowledge Base Entry Screen (Fig. 2) and the physician chooses to Enter/Update Disorder. The Disorder Data Entry Screen (Fig. 3) appears with the first unused disorder number already filled in, but the physician is required to type in the disorder name, the category, the prevalence rate, the severity code, as well as a four line description, which is later used by the explanation and treatment Systems. The physician is now ready to enter the disorder pattern for Pulmonary Thromboembolism. The disorder pattern for a disease lists all the features relevant to the disorder and the associated conditional probabilities. MEDAS must store both p(f/d+), the probability that the feature is present given that the patient has the disorder, and p(f/d-), the probability that the feature is present given that the patient does not have the disorder for use by the diagnostic consultant. 2 The Disorder Pattern Entry Screen (Fig. 4A) allows the physician to enter estimates of these probabilities. The system then calculates the ratio between p(f/d+) and p(f/d-) which serves as a measure of the contribution of this feature. The Disorder Pattern Screen lists features in the order of the feature number. A sort option permits the features in a disorder pattern to be listed in a number of different ways. If the physician wants to check whether a particular feature is present, he/she may ask for the features in alphabetical order as seen in Figure 4B. To check instead whether the probability estimates are consistent, the physician may ask for a screen sorted by feature probability ratios, as seen in Figure 4C. Now that the disorder pattern has been entered, the physician can use the Knowledge Base Test Option in the TOOLBOX to try it out. The Test Option runs a modified version of the MEDAS system using the newly updated version of the Knowledge Base. The physician can enter a hypothetical case or even use a patient record from the MEDAS library of test patients. Cases can be saved and rerun when further changes are made to the Knowledge Base. The following is a hypothetical case. Our patient is a 60 year old, white gentleman with a history of Ischemic Heart Disease (I.H.D.) and Congestive Heart Failure (CHF), admitted to the hospital with a sudden onset of chest discomfort, dyspnea, diaphoresis and non-productive cough. He also has a history of smoking as well as a strong family history of I.H.D. The patient's physical examination indicated a temperature of 98.8 F, regular pulse rate of 116/min., a blood pressure of 160/110, and a respiratory rate of 28/min. His skin is cold and pale. He is sweating. Auscultation of his heart revealed an S4 gallop rhythm. His lungs were essentially clear to auscultation. The patient's electrocardiogram showed ST segment depression in anterolateral leads as well as T wave inversion in the same leads. Arterial blood gases showed a PCO2 of 28 mmhg and PO2 of 68 mmhg. Serum CKMB enzymes were measured and revealed 2 units/liter. The Ventilation/Perfusion (V/P) scan showed multiple segmental perfusion defects with mismatched ventilation. Impedance Plethysmography of the lower extremities showed evidence of deep vein thrombosis. These findings are diagnostic of pulmonary thromboembolism due to deep vein thrombosis. To our expert's dismay, the first test case run (using MEDAS-R) is diagnosed by the system as having a Myocardial Infarction instead of a Pulmonary Thromboembolism (Figures 5A,5B,5C). To determine the reason for the "wrong" diagnosis, the expert can call up a Disorder Differentiation Report (Fig. 6). This report compares Myocardial Infarction and Pulmonary Thromboembolism in detail showing the contribution of each feature. If the difference between the probability ratios of a given feature is small, then the feature is not useful for discriminating between the two disorders. If the discriminating features are not sufficiently robust, the Knowledge Base author should add one or more new features to the disorder pattern. The physician researches the options and identifies that Impedance Plethysmography (IPG) makes an important contribution in the diagnosis of Pulmonary Thromboembolism. 8 A positive IPG in the setting of the V/P lung scan, an embolism has a very high probability

3 of establishing the diagnosis of Pulmonary Thromboembolism and almost equals the diagnostic specificities of Pulmonary angiography, accordingly this is a more invasive test with its added risks, discomfort and cost. In this case, we need to add new features to the Pulmonary Thromboembolism disorder pattern. Entering a New Feature The first step in entering a new feature is to call up the Feature Data Entry Screen (Fig. 7). The system provides the next unused feature number, but the expert must enter the rest of the information. First comes the feature names: V/P lung scan, Mismatched Ventilation, and IPG. The feature category here is "Radiology." Other possible categories are complaint, S/O (setting of), H/O (history of), physical examination, and laboratory tests. The display key indicates where the feature is to be displayed on the screen when MEDAS is being used as a diagnostic consultant. Features including age, sex, and race are entered when the patient is admitted and cannot be changed; these features are classified as "admission-only features". When a feature is marked as "assumed negative", the system assumes that the feature is assumed to be absent (negative) unless the user consulting the system specifies that it is present (positive). The description is used by the explanation system. The cost code is used for measuring the cost associated with collecting this information. The current system is using numbers from one to five, this range could be changed for more elaborate measurement of cost and quality control. In this implementation, for example, an invasive and possibly dangerous test like a pulmonary angiogram has a cost code of 5, while a non-invasive test like IPG will have a cost code of 2. Our expert is also interested in the feature Dyspnea. This feature is already in the system. For what other diseases is this a relevant feature? What other disorder patterns does it belong to? The expert can find this information in the Feature Pattern Report for Dyspnea (Fig. 8). The system can produce such a report for every feature in the system. Since there are more than 700 features, this information is not stored in the Knowledge Base. Instead, it is computed whenever the medical expert calls for it. Whenever a new feature is entered it is very important for the expert to also consider the way it interacts with other features and enter this information into the system as well. To do this the physician calls up the Feature-Feature Interaction Entry Screen (Fig. 9). All related features should be entered on this screen along with the nature of the interaction. To give a simple example, whenever the feature "female" is marked as present (+), the related feature "male" must be marked as absent (-). Conversely, when female is marked as absent (-), "male" must be marked as present (+). In addition, the S/O abortion must be marked as absent (-). IPG, therefore, with regards to our hypothetical case, interacts with the past treatment of Deep Venous Thrombosis (DVT), as well as venous insufficiency. It is at this time then, that the physician can recall the same patient and enter (mark) the newly created feature. This in turn would make it possible to compute the probabilities with these modifications as shown in Figures 5D and 5E. Comment We have described a set of knowledge engineering tools for the pattern-based system MEDAS, that help the physician to add new diseases and symptoms, and detect inconsistencies in the knowledge base. The physician can also insert or correct probability estimates as the medical literature brings new information and broadens the physician's knowledge. Currently we are using the MEDAS-R in conjunction with EMYCIN in our 4 week senior elective, which presents to our student the use of computers in medical diagnostics. The new tools provide the students time to work with Disorder and Feature interactions and not be bogged down with the technical aspects of man-machine interface. We have many plans for the future of MEDAS. The appearance of high performance low-priced microcomputers has made the development of a micro version of MEDAS a high priority, with the aim of making the system cheap enough so that every hospital emergency room can afford one. We are studying the internal strucutre of our treatment protocols with the aim of developing an entity-relationship model and then a relational database for treatment information to work with MEDAS. We hope to compare the performance of MEDAS using probability estimates derived from large public domain database like the National Stroke Registry with its performance using the subjective estimates of physicians as now.

4 Acknowledgement ACCENT-R is a trademark of National Information Systems, Cupertino, CA. References [1] Koschmann, T., Evens, M.; Naeymi-Rad, F., Gudipati, R., Lee, C.M., Weil, M.H. "Knowledge Engineering Tools for a Bayesian Diagnostic Consultant." Submitted to Ninth Annual Symposium on Computer Applications in Medical Care, [2] Ben-Bassat, M., Carlson, R.W., Pun, V.K., Davenport, M.D., Schnver, J.A., Lahf, M., Smith, R., Portigal, L.D., Lipnick, E.H., and Weil, M.H. Pattern-Based Interactive Diagnosis of Multiple Disorders: The MEDAS System," PAMI-2, No. 2, March, 1980, [3] Buchanan B., and Shortliffe, E. (Eds.). Rule-Based Expert Systems, Addison-Wesley, Reading, MA, [4] Davis, R., and Lenat, D. Knowledge-Based Systems in Artificial Intelligence, Mc- Graw-Hill, New York, [5] Ben-Bassat, M. "Multimembership and Multiperspective Classification: Introduction, Applications, and a Bayesian Model," IEEE Transactions on Systems, Man, and Cybernetics SMC-10, 1980, [6] Ben-Bassat, M., Carlson, R.W. Puri V.K., and Weil, M.H. "A Hieraichicai Modular Design for Treatment Protocols," Meth. Inform Med., Vol. 19, No. 2, April, 1980, [7] Koschmann, T., Solomon, D.. Naeymi-Rad, F., Evens, M., Weil M.H., and Rackow, E.C. "Relational Storage Techniques as Applied to a Medical Expert System," Proc Conference on Intelligent Systems and Machines, Rochester, Michigan April, 1984 [8] Hull, R.D., et.al. "Pulmonary Angiography Ventilation Lung Scanning and Venography for Clinically Suspected Pulmonary Embolism with Abnormal Perfusion Lung Scan," Annals of Internal Medicine, Vol. 98, No. 6, June, 1983,

5 Figures Mar. 4, 1985 <<MEDAS KNOWLEDGE BASE TOOBOX>> Screen No. 9:32:35 AM Developed by UHS/CMS Computer Center MEDMOO 1 -- Look at Help and Background Information 2 -- Knowledge Base Entry KnowledgeBase Report Knowledge Base Convert. S -- Knowledge Base Test (MEDAS R) Treatment Entry Treatment Reports Exit Select one of the above. > _ FIGURE #l Mar. 4, 1985 <<MEDAS KNOWLEDGE BASE TOOBOX>> Screen No. 9:32:35 AM Developed by UHS/CMS Computer Center MEDM Enter/Update Disorder Enter/Update Fedfure Enter/UpUdte Probability, 4 -- Enter/UpddLe Fedture Interd~tion Exit. Select one ol the above. > _ FIGURE #2 Mar. 4, 1985 <<DISORDER DATAENTRY>> Screen No. 9:32:35 AM Developed by UHS/CMS Computer Center MEDS10 Disorder # (or STOP): 12 1) Category #: I CNAME. RESPIRATORY 2) Intl disease code: 415,1 3) Disorder name: PULMONARY THRDM80EM80LISM 4) Prevalence rate:.020 S) Severity code: 4 6) Descr 1 : EMB0LISM OF THE PULMONARY ARTERIAL 7) Descr 2 : VESSELS RESULTING FRDM VENOUS 8) Descr 3 : THROMBOSIS WITH ORWlTHOUT PULMONARY 9) Descr 4 : INFARCTION. Do you have any changes? (# / N) >> FIGURE #3

6 FIGURE #4A Disorder Pattern Entry Screen Showing Features in F# Order. FIGURE #4B Disorder Pattern Entry Screen Showing the Features in Alphabetical Order, by Feature Name

7 FIGURE #4C Disorder Pattern Entry Screen Showing the Features in Ratio Order FIGURE #5A Diagnostic Consultant Screen from MEDAS FIGURE #5B Justification for the Posterior Probability for Acute Myocardial Infarction

8 FIGURE #5C Justification for the Posterior Probability of Pulmonary Thromboembolism FIGURE#5D The Result of the Diagnostic Consultant Screen After a New Disorder is Added for Pulmonary Thromboembolism FIGURE #5E An Explanatlon for Pulmonary Thromboembolism Diagnosis

9 FIGURE #6 This Report has Three Sections: 1) Features that are Found in Common Between the Two Disorders 2) Features in the First Disorder, and 3) Features in the Second Disorder FIGURE #7

10 FIGURE #8 Feature Pattern Report for DYSPNEA FIGURE #9 Feature-Feature Interactlon Entry Screen

EXHIBIT H SETTLEMENT ELIGIBILITY CRITERIA. a) pharmacy records reflecting the dispensing of Bextra and/or Celebrex to the Class Member; or

EXHIBIT H SETTLEMENT ELIGIBILITY CRITERIA. a) pharmacy records reflecting the dispensing of Bextra and/or Celebrex to the Class Member; or EXHIBIT H SETTLEMENT ELIGIBILITY CRITERIA 1. PRODUCT IDENTIFICATION DOCUMENTATION In order to be eligible for compensation under the Settlement Agreement, each Claimant must provide evidence of the Class

More information

GENERAL HEART DISEASE KNOW THE FACTS

GENERAL HEART DISEASE KNOW THE FACTS GENERAL HEART DISEASE KNOW THE FACTS WHAT IS Heart disease is a broad term meaning any disease affecting the heart. It is commonly used to refer to coronary heart disease (CHD), a more specific term to

More information

Investor News. Not intended for U.S. and UK media

Investor News. Not intended for U.S. and UK media Investor News Not intended for U.S. and UK media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer s Xarelto (Rivaroxaban) Approved for the Treatment of Pulmonary Embolism

More information

Ischemia and Infarction

Ischemia and Infarction Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Badizadegan Ischemia and Infarction HST.035 Spring 2003 In the US: ~50% of deaths are due to

More information

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN HOSPITALIZATION CASE #: 2 8 8 0 H FY288BH4CN Has the participant indicated any of the following reasons for being admitted overnight for this case? 1. Suspected or confirmed problems with the heart, circulation,

More information

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart

More information

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology

More information

James F. Kravec, M.D., F.A.C.P

James F. Kravec, M.D., F.A.C.P James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice

More information

Your Guide to Express Critical Illness Insurance Definitions

Your Guide to Express Critical Illness Insurance Definitions Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses

More information

Confirmed Deep Vein Thrombosis (DVT)

Confirmed Deep Vein Thrombosis (DVT) Confirmed Deep Vein Thrombosis (DVT) Information for patients What is deep vein thrombosis? Blood clotting provides us with essential protection against severe loss of blood from an injury to a vein or

More information

BAYESIAN BELIEF NETWORKS AS A DIAGNOSTIC TOOL FOR PULMONARY EMBOLISM

BAYESIAN BELIEF NETWORKS AS A DIAGNOSTIC TOOL FOR PULMONARY EMBOLISM BAYESIAN BELIEF NETWORKS AS A DIAGNOSTIC TOOL FOR PULMONARY EMBOLISM Rohit Bodas 1, Shailesh Deshpande 1, Gursel Serpen 1, E. Ishmael Parsai 2, Robert J. Coombs 3 and Lee S. Woldenberg 3 1 Electrical Engineering

More information

Acute Coronary Syndrome. What Every Healthcare Professional Needs To Know

Acute Coronary Syndrome. What Every Healthcare Professional Needs To Know Acute Coronary Syndrome What Every Healthcare Professional Needs To Know Background of ACS Acute Coronary Syndrome (ACS) is an umbrella term used to cover a spectrum of clinical conditions that are caused

More information

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological

More information

CHAPTER 4 QUALITY ASSURANCE AND TEST VALIDATION

CHAPTER 4 QUALITY ASSURANCE AND TEST VALIDATION CHAPTER 4 QUALITY ASSURANCE AND TEST VALIDATION CINDY WEILAND AND SANDRA L. KATANICK Continued innovations in noninvasive testing equipment provide skilled sonographers and physicians with the technology

More information

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 PROJECT TITLE: Analysis of ECG Exercise Stress Testing and Framingham Risk Score in Chest Pain Patients PRIMARY SUPERVISOR NAME: Dr. Edward Tan DEPARTMENT:

More information

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali

More information

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT

More information

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients

More information

Patient Information Leaflet: Part 1 select-d

Patient Information Leaflet: Part 1 select-d Patient Information Leaflet: Part 1 select-d Anticoagulation Therapy in SELECTeD Cancer Patients at Risk of Recurrence of Venous Thromboembolism Introduction This

More information

Heart Failure EXERCISES. Ⅰ. True or false questions (mark for true question, mark for false question. If it is false, correct it.

Heart Failure EXERCISES. Ⅰ. True or false questions (mark for true question, mark for false question. If it is false, correct it. Heart Failure EXERCISES Ⅰ. True or false questions (mark for true question, mark for false question. If it is false, correct it. ) 1. Heart rate increase is a kind of economic compensation, which should

More information

Clinical Decision Support Systems. Dr. Adrian Mondry

Clinical Decision Support Systems. Dr. Adrian Mondry Clinical Decision Support Systems Dr. Adrian Mondry Medical practice is decision making! Types of decisions in medicine: Diagnosis Diagnostic process Management of treatment Resource management in a hospital

More information

Informed Consent Form for Testosterone Therapy

Informed Consent Form for Testosterone Therapy Student Health Services Oregon State University, 201 Plageman Building, Corvallis, Oregon 97331-8567 Tel 541-737-9355 General Fax 541-737-4530 Medical Fax 541-737-9665 http://studenthealth.oregonstate.edu/

More information

UW MEDICINE PATIENT EDUCATION. Aortic Stenosis. What is heart valve disease? What is aortic stenosis?

UW MEDICINE PATIENT EDUCATION. Aortic Stenosis. What is heart valve disease? What is aortic stenosis? UW MEDICINE PATIENT EDUCATION Aortic Stenosis Causes, symptoms, diagnosis, and treatment This handout describes aortic stenosis, a narrowing of the aortic valve in your heart. It also explains how this

More information

A PATIENT S GUIDE TO PULMONARY EMBOLISM TREATMENT

A PATIENT S GUIDE TO PULMONARY EMBOLISM TREATMENT A PATIENT S GUIDE TO PULMONARY EMBOLISM TREATMENT This medicine is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk to

More information

Problem-Centered Care Delivery

Problem-Centered Care Delivery HOW INTERFACE TERMINOLOGY MAKES STANDARDIZED HEALTH INFORMATION POSSIBLE Terminologies ensure that the languages of medicine can be understood by both humans and machines. by June Bronnert, RHIA, CCS,

More information

Creating a Hybrid Database by Adding a POA Modifier and Numerical Laboratory Results to Administrative Claims Data

Creating a Hybrid Database by Adding a POA Modifier and Numerical Laboratory Results to Administrative Claims Data Creating a Hybrid Database by Adding a POA Modifier and Numerical Laboratory Results to Administrative Claims Data Michael Pine, M.D., M.B.A. Michael Pine and Associates, Inc. mpine@consultmpa.com Overview

More information

Suspected pulmonary embolism (PE) in pregnant women

Suspected pulmonary embolism (PE) in pregnant women Suspected pulmonary embolism (PE) in pregnant women What is a pulmonary embolus? A deep vein thrombosis (DVT) is a blood clot that forms in one of the deep veins of the leg. If the clot moves to the lung,

More information

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics Yen Tibayan, M.D. Division of Cardiovascular Medicine Case Presentation 69 y.o. woman calls 911 with the complaint of

More information

ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE)

ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE) ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE) Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet has

More information

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF

More information

Vtial sign #1: PULSE. Vital Signs: Assessment and Interpretation. Factors that influence pulse rate: Importance of Vital Signs

Vtial sign #1: PULSE. Vital Signs: Assessment and Interpretation. Factors that influence pulse rate: Importance of Vital Signs Vital Signs: Assessment and Interpretation Elma I. LeDoux, MD, FACP, FACC Associate Professor of Medicine Vtial sign #1: PULSE Reflects heart rate (resting 60-90/min) Should be strong and regular Use 2

More information

Information for you Treatment of venous thrombosis in pregnancy and after birth. What are the symptoms of a DVT during pregnancy?

Information for you Treatment of venous thrombosis in pregnancy and after birth. What are the symptoms of a DVT during pregnancy? Information for you Treatment of venous thrombosis in pregnancy and after birth Published in September 2011 What is venous thrombosis? Thrombosis is a blood clot in a blood vessel (a vein or an artery).

More information

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE CASE REPORT: ACUTE STROKE MANAGEMENT 90 YEAR OLD WOMAN, PREVIOUSLY ACTIVE AND INDEPENDENT, CHRONIC ATRIAL FIBRILLATION,

More information

California Health and Safety Code, Section 1256.01

California Health and Safety Code, Section 1256.01 California Health and Safety Code, Section 1256.01 1256.01. (a) The Elective Percutaneous Coronary Intervention (PCI) Pilot Program is hereby established in the department. The purpose of the pilot program

More information

Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium

Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium October 30, 2008 Barry Libman, RHIA, CCS, CCS-P President, Barry Libman Inc. Stroke Coding Issues Outline Medical record documentation

More information

XARELTO (rivaroxaban tablets) in Knee and Hip Replacement Surgery

XARELTO (rivaroxaban tablets) in Knee and Hip Replacement Surgery XARELTO (rivaroxaban tablets) in Knee and Hip Replacement Surgery Fast Facts: XARELTO is a novel, once-daily, oral anticoagulant recently approved in the United States for the prevention (prophylaxis)

More information

Horton General Hospital Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Information for patients

Horton General Hospital Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Information for patients Horton General Hospital Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Information for patients What is a Deep Vein Thrombosis (DVT)? A DVT is a blood clot which forms in a deep vein, usually in

More information

Lifecheque Basic Critical Illness Insurance

Lifecheque Basic Critical Illness Insurance Lifecheque Basic Critical Illness Insurance Strong. Reliable. Trustworthy. Forward-thinking. Extra help on the road to recovery Surviving a critical illness can be very challenging financially Few of us

More information

The P Wave: Indicator of Atrial Enlargement

The P Wave: Indicator of Atrial Enlargement Marquette University e-publications@marquette Physician Assistant Studies Faculty Research and Publications Health Sciences, College of 8-12-2010 The P Wave: Indicator of Atrial Enlargement Patrick Loftis

More information

Informatics In Medical Education

Informatics In Medical Education Informatics In Medical Education 1 Frank Naeymi-Rad, Ph.D. 1, David Trace, M.D. 1, Khalid Moidu, M.D., Ph.D. 2, Lowell Carmony, PhD 3, and Theodore Booden, Ph.D. 1 1 Finch University of Health Sciences/The

More information

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.

More information

Introduction. What is syncope?

Introduction. What is syncope? Syncope Introduction What is syncope? Syncope (SING-kuh-pee) is a medical term for fainting. When you faint, your brain is not receiving enough blood and oxygen, so you lose consciousness temporarily.

More information

Medical Records Analysis

Medical Records Analysis Medical Records Analysis Karen A. Mulroy, Partner Evans & Dixon, L.L.C. The analysis of medical legal issues posed in any case can be complicated, requiring some close reading and detective work to both

More information

Redefining the NSTEACS pathway in London

Redefining the NSTEACS pathway in London Redefining the NSTEACS pathway in London Sotiris Antoniou Consultant Pharmacist, Cardiovascular Medicine, Barts and The London NHS Trust and Project Lead, North East London Cardiovascular and Stroke Network

More information

Pulmonary Rehabilitation. Use it or lose it??? By John R. Goodman BS RRT

Pulmonary Rehabilitation. Use it or lose it??? By John R. Goodman BS RRT Pulmonary Rehabilitation Use it or lose it??? By John R. Goodman BS RRT Of all the forms of Rehabilitation that are available in medicine, pulmonary rehabilitation is a relative newcomer. For example Cardiac

More information

Ventilation Perfusion Relationships

Ventilation Perfusion Relationships Ventilation Perfusion Relationships VENTILATION PERFUSION RATIO Ideally, each alveolus in the lungs would receive the same amount of ventilation and pulmonary capillary blood flow (perfusion). In reality,

More information

DIAGNOSTIC CRITERIA OF STROKE

DIAGNOSTIC CRITERIA OF STROKE DIAGNOSTIC CRITERIA OF STROKE Diagnostic criteria are used to validate clinical diagnoses. Here below MONICA diagnostic criteria are reported. MONICA - MONItoring trends and determinants of CArdiovascular

More information

CARDIAC CARE. Giving you every advantage

CARDIAC CARE. Giving you every advantage CARDIAC CARE Giving you every advantage Getting to the heart of the matter The Cardiovascular Program at Northwest Hospital & Medical Center is dedicated to the management of cardiovascular disease. The

More information

Medicare Advantage Risk Adjustment Data Validation CMS-HCC Pilot Study. Report to Medicare Advantage Organizations

Medicare Advantage Risk Adjustment Data Validation CMS-HCC Pilot Study. Report to Medicare Advantage Organizations Medicare Advantage Risk Adjustment Data Validation CMS-HCC Pilot Study Report to Medicare Advantage Organizations JULY 27, 2004 JULY 27, 2004 PAGE 1 Medicare Advantage Risk Adjustment Data Validation CMS-HCC

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

Level 1 Tower C Global Business Park MG Road Gurgaon,122 002 India T+91 124 406 2500 F+91 124 406 8536 goindigo.in

Level 1 Tower C Global Business Park MG Road Gurgaon,122 002 India T+91 124 406 2500 F+91 124 406 8536 goindigo.in APPLICATION FOR CARRIAGE OF MEDICAL PASSENGERS Detailed Medical Certificate must accompany this completed form. Medical Passenger Completed Application to be forwarded to the Medical Department DEL for

More information

Bayfront. Heart Center. www.bayfrontheart.org

Bayfront. Heart Center. www.bayfrontheart.org Bayfront Heart Center www.bayfrontheart.org THE HEART OF THE MATTER At the Bayfront Heart Center, the leading cardiac facility in the area, we are fully equipped to treat all aspects of cardiovascular

More information

X-ray (Radiography) - Chest

X-ray (Radiography) - Chest Scan for mobile link. X-ray (Radiography) - Chest What is a Chest X-ray (Chest Radiography)? The chest x-ray is the most commonly performed diagnostic x-ray examination. A chest x-ray produces images of

More information

USE OF TEXTURES FOR MONITORING THE TREATMENT OF LEG ULCERS

USE OF TEXTURES FOR MONITORING THE TREATMENT OF LEG ULCERS USE OF TEXTURES FOR MONITORING THE TREATMENT OF LEG ULCERS Gilmar Caiado Fleury Medeiros a João Eduardo Borelli b Adilson Gonzaga c a, c University of São Paulo, São Carlos Engineering School, Electrical

More information

National Learning Objectives for COPD Educators

National Learning Objectives for COPD Educators National Learning Objectives for COPD Educators National Learning Objectives for COPD Educators The COPD Educator will be able to achieve the following objectives. Performance objectives, denoted by the

More information

GENERAL INFORMATION. Adverse Event (AE) Definition (ICH GUIDELINES E6 FOR GCP 1.2):

GENERAL INFORMATION. Adverse Event (AE) Definition (ICH GUIDELINES E6 FOR GCP 1.2): Make copies of the blank SAE report form as needed. Retain originals with confirmation of all information faxed to DMID Pharmacovigilance Group Clinical Research Operations and Management Support (CROMS

More information

What You Should Know About Cerebral Aneurysms

What You Should Know About Cerebral Aneurysms What You Should Know About Cerebral Aneurysms From the Cerebrovascular Imaging and Interventions Committee of the American Heart Association Cardiovascular Radiology Council Randall T. Higashida, M.D.,

More information

Overview. Geriatric Overview. Chapter 26. Geriatrics 9/11/2012

Overview. Geriatric Overview. Chapter 26. Geriatrics 9/11/2012 Chapter 26 Geriatrics Slide 1 Overview Trauma Common Medical Emergencies Special Considerations in the Elderly Medication Considerations Abuse and Neglect Expanding the Role of EMS Slide 2 Geriatric Overview

More information

Atrial Fibrillation An update on diagnosis and management

Atrial Fibrillation An update on diagnosis and management Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.

More information

Medical Knowledge-Based System for Diagnosis from Symptoms and Signs

Medical Knowledge-Based System for Diagnosis from Symptoms and Signs 54 W. Wiriyasuttiwong and W. Narkbuakaew: Medical Knowledge-Based System for... (54-59) Medical Knowledge-Based System for Diagnosis from Symptoms and Signs Watcharachai Wiriyasuttiwong* and Walita Narkbuakaew,

More information

Implementing Medical Checkups to Prevent. Sports-Related Injuries and Disorders

Implementing Medical Checkups to Prevent. Sports-Related Injuries and Disorders Sports-Related Injuries and Disorders Implementing Medical Checkups to Prevent Sports-Related Injuries and Disorders JMAJ 48(1): 1 5, 2005 Hideo MATSUMOTO*, Toshiro OTANI**, Hitoshi ABE*** and Yasunori

More information

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Long-term prevention of venous blood clots (VTE): Bayer Initiates Rivaroxaban

More information

University of Kansas. Respiratory Care Education

University of Kansas. Respiratory Care Education University of Kansas Respiratory Care Education What is Respiratory Care? Respiratory Care is the health profession that specializes in the promotion of optimum cardiopulmonary function and health Respiratory

More information

Emergency Scenario. Chest Pain

Emergency Scenario. Chest Pain Emergency Scenario Chest Pain This emergency scenario reviews chest pain in a primary care patient, and is set up for roleplay and case review with your staff. 1) The person facilitating scenarios can

More information

X-ray (Radiography), Chest

X-ray (Radiography), Chest X-ray (Radiography), Chest What is a Chest X-ray (Chest Radiography)? The chest x-ray is the most commonly performed diagnostic x-ray examination. A chest x-ray makes images of the heart, lungs, airways,

More information

Cardiac Rehabilitation. Exercise and Education Program

Cardiac Rehabilitation. Exercise and Education Program Cardiac Rehabilitation Exercise and Education Program Cardiac Rehabilitation Dear Patient: Cardiac rehabilitation is an important part of your recovery. Our progressive cardiac rehabilitation program

More information

Heart Center Packages

Heart Center Packages Heart Center Packages For more information and appointments, Please contact The Heart Center of Excellence at the American Hospital Dubai Tel: +971-4-377-6571 Email: heartcenter@ahdubai.com www.ahdubai.com

More information

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT)

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT) ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT) Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet

More information

2011 Radiology Diagnosis Coding Update Questions and Answers

2011 Radiology Diagnosis Coding Update Questions and Answers 2011 Radiology Diagnosis Coding Update Questions and Answers How can we subscribe to the Coding Clinic for ICD-9 guidelines and updates? The American Hospital Association publishes this quarterly newsletter.

More information

Ischaemic stroke 85% (85 in every 100 strokes)

Ischaemic stroke 85% (85 in every 100 strokes) UNDERSTANDING STROKE DUE TO INTRACEREBRAL HAEMORRHAGE This factsheet provides information for people who have had a stroke due to an intracerebral (bleed in the brain) and for their families and carers.

More information

ECG may be indicated for patients with cardiovascular risk factors

ECG may be indicated for patients with cardiovascular risk factors eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,

More information

Paul G. Lee. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume III, 1998-1999. A. Objective

Paul G. Lee. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume III, 1998-1999. A. Objective A comparison of six months of anticoagulation with extended anticoagulation for a first episode of venous thromboembolism in patients with thrombophilia Paul G. Lee A. Objective a. To evaluate the risk

More information

cobas h 232 POC system On-the-spot care & share

cobas h 232 POC system On-the-spot care & share cobas h 232 POC system On-the-spot care & share Confident on-the-spot diagnosis of patients presenting with life-threatening chest pain or dyspnea. Plus wireless connectivity for immediate, streamlined

More information

Documenting & Coding. Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC

Documenting & Coding. Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC Documenting & Coding Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC Sr. Provider Training & Development Consultant Professional Profile David Brigner currently performs

More information

Raising Sleep Apnea Awareness:

Raising Sleep Apnea Awareness: Raising Sleep Apnea Awareness: Among People with Diabetes in North Carolina, 2012 People with diabetes have more sleep problems than people without diabetes in the same age, sex, and race/ethnicity group.

More information

LoanProtector Certificate of Insurance - Loan and Line of Credit life, critical illness and disability insurance

LoanProtector Certificate of Insurance - Loan and Line of Credit life, critical illness and disability insurance Page 1 of 6 This Certificate of Insurance ("Certificate") provides important details on your coverage; please keep this Certificate in a safe place. Subsequent correspondence may refer to this Certificate

More information

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200 GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung

More information

Respiratory Therapy Careers. CTAE Resource Network Created by Caleb Allred and Dr. Frank Flanders 2010

Respiratory Therapy Careers. CTAE Resource Network Created by Caleb Allred and Dr. Frank Flanders 2010 Respiratory Therapy Careers CTAE Resource Network Created by Caleb Allred and Dr. Frank Flanders 2010 Objectives MSHS7-HS-4: Students will differentiate careers available in the field of respiratory care.

More information

Chronic Thromboembolic Disease. Chronic Thromboembolic Disease Definition. Diagnosis Prevention Treatment Surgical Nonsurgical

Chronic Thromboembolic Disease. Chronic Thromboembolic Disease Definition. Diagnosis Prevention Treatment Surgical Nonsurgical Chronic Thromboembolic Disease Diagnosis Prevention Treatment Surgical Nonsurgical Chronic Thromboembolic Disease Definition Pulmonary Hypertension due to chronic thromboembolism 6 months post acute PE:

More information

Transforming Emergency Care for Seniors

Transforming Emergency Care for Seniors Transforming Emergency Care for Seniors BMC 00135 7x10 Brochure 2.indd 1 Welcome to the region s first Senior ER at University Hospitals Bedford Medical Center. Welcome to the ER designed specifically

More information

Predicting the Risk of Heart Attacks using Neural Network and Decision Tree

Predicting the Risk of Heart Attacks using Neural Network and Decision Tree Predicting the Risk of Heart Attacks using Neural Network and Decision Tree S.Florence 1, N.G.Bhuvaneswari Amma 2, G.Annapoorani 3, K.Malathi 4 PG Scholar, Indian Institute of Information Technology, Srirangam,

More information

FEMALE DRIVER S LICENSE NUMBER STATE ISSUED PLACE OF BIRTH CITY STATE CITY STATE ZIP CITY STATE ZIP COUNTY USA

FEMALE DRIVER S LICENSE NUMBER STATE ISSUED PLACE OF BIRTH CITY STATE CITY STATE ZIP CITY STATE ZIP COUNTY USA PATIENT S INFORMATION NAME (Last, First, Middle) PREVIOUS LAST NAME NICKNAME SOCIAL SECURITY NUMBER BIRTH SEX MALE FEMALE DRIVER S LICENSE NUMBER STATE ISSUED PLACE OF BIRTH CITY STATE PATIENT S BILLING/MAILING

More information

Term Critical Illness Insurance

Term Critical Illness Insurance Term Critical Illness Insurance PRODUCT GUIDE 5368-01A-JUL14 ASSUMPTION LIFE This document is a summary of the various features of Assumption Life's products. It is neither a contract nor an insurance

More information

Screening for Critical Congenital Heart Disease in the Apparently Healthy Newborn

Screening for Critical Congenital Heart Disease in the Apparently Healthy Newborn Screening for Critical Congenital Heart Disease in the Apparently Healthy Newborn A presentation of Texas Pulse Oximetry Project: A Joint Educational Initiative of The University of Texas Health Science

More information

"Statistical methods are objective methods by which group trends are abstracted from observations on many separate individuals." 1

Statistical methods are objective methods by which group trends are abstracted from observations on many separate individuals. 1 BASIC STATISTICAL THEORY / 3 CHAPTER ONE BASIC STATISTICAL THEORY "Statistical methods are objective methods by which group trends are abstracted from observations on many separate individuals." 1 Medicine

More information

CBT/OTEP 243 Aspirin Administration for ACS

CBT/OTEP 243 Aspirin Administration for ACS Seattle-King County EMS Seattle-King County Emergency Medical Services Division Public Health - Seattle/King County 401 5th Avenue, Suite 1200 Seattle, WA 98104 (206) 296-4693 February 2009 CBT/OTEP 243

More information

Fainting - Syncope. This reference summary explains fainting. It discusses the causes and treatment options for the condition.

Fainting - Syncope. This reference summary explains fainting. It discusses the causes and treatment options for the condition. Fainting - Syncope Introduction Fainting, also known as syncope, is a temporary loss of consciousness. It is caused by a drop in blood flow to the brain. You may feel dizzy, lightheaded or nauseous before

More information

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications

More information

Hot Line Session at European Society of Cardiology (ESC) Congress 2014:

Hot Line Session at European Society of Cardiology (ESC) Congress 2014: Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Hot Line Session at European Society of Cardiology (ESC) Congress 2014: Once-Daily

More information

Acute heart failure may be de novo or it may be a decompensation of chronic heart failure.

Acute heart failure may be de novo or it may be a decompensation of chronic heart failure. Management of Acute Left Ventricular Failure Acute left ventricular failure presents as pulmonary oedema due to increased pressure in the pulmonary capillaries. It is important to realise though that left

More information

A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT

A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT This medicine is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk

More information

Venous Thrombosis and Pulmonary Embolism Treatment with Rivaroxaban

Venous Thrombosis and Pulmonary Embolism Treatment with Rivaroxaban Venous Thrombosis and Pulmonary Embolism Treatment with Rivaroxaban Information for patients and families Read this booklet to learn: about venous thrombosis and pulmonary embolism how the medicine Rivaroxaban

More information

Description of the OECD Health Care Quality Indicators as well as indicator-specific information

Description of the OECD Health Care Quality Indicators as well as indicator-specific information Appendix 1. Description of the OECD Health Care Quality Indicators as well as indicator-specific information The numbers after the indicator name refer to the report(s) by OECD and/or THL where the data

More information

Cardiac Rehabilitation

Cardiac Rehabilitation Cardiac Rehabilitation Exercise and Education Program Always thinking. Always caring. Cardiac Rehabilitation Dear Patient: Cardiac rehabilitation is an important part of your recovery. Our progressive

More information

2.1 Who first described NMO?

2.1 Who first described NMO? History & Discovery 54 2 History & Discovery 2.1 Who first described NMO? 2.2 What is the difference between NMO and Multiple Sclerosis? 2.3 How common is NMO? 2.4 Who is affected by NMO? 2.1 Who first

More information

Nursing Process. What Is Nursing Diagnosis (Dx)? Step 2: Nursing Diagnosis Step 3: Outcome Identification. Nursing Diagnosis.

Nursing Process. What Is Nursing Diagnosis (Dx)? Step 2: Nursing Diagnosis Step 3: Outcome Identification. Nursing Diagnosis. Nurse Caring Concepts 1A Nursing Process Step 2: Nursing Diagnosis Step 3: Outcome Identification Week 6 September 22, 2003 What Is Nursing Diagnosis (Dx)? Has two related meanings: Nursing diagnosis is

More information

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban

More information

Prediction of Heart Disease Using Naïve Bayes Algorithm

Prediction of Heart Disease Using Naïve Bayes Algorithm Prediction of Heart Disease Using Naïve Bayes Algorithm R.Karthiyayini 1, S.Chithaara 2 Assistant Professor, Department of computer Applications, Anna University, BIT campus, Tiruchirapalli, Tamilnadu,

More information

Heart Attack: What You Need to Know

Heart Attack: What You Need to Know A WorkLife4You Guide Heart Attack: What You Need to Know What is a Heart Attack? The heart works 24 hours a day, pumping oxygen and nutrient-rich blood to the body. Blood is supplied to the heart through

More information

Chest Pain in Young Athletes. Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego cdavis@rchsd.

Chest Pain in Young Athletes. Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego cdavis@rchsd. Chest Pain in Young Athletes Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego cdavis@rchsd.org 858-966-5855 None Disclosures Chest Pain: the good news and the bad news:

More information